The bacterial cell wall is made of peptidoglycan (PG), a polymer that is 22 essential for maintenance of cell shape and survival. During growth, bacteria remodel 23 their PG, releasing fragments that are predominantly re-internalized by the cell, 24 where they are recycled for synthesis of new PG. Although the PG recycling pathway 25 is widely conserved, its components are not essential and its roles in cell wall 26 homeostasis are not well-understood. Here, we identified LdcV, a Vibrio cholerae 27 L,D-carboxypeptidase that cleaves the terminal D-Alanine from recycled 28 murotetrapeptides. In the absence of ldcV, recycled tetrapeptides accumulated in the 29 cytosol, leading to two toxic consequences for the cell wall. First, incorporation of 30 tetrapeptide-containing PG precursors into the cell wall led to reduction in D,D-cross-31 linkage between stem peptides, diminishing PG integrity. Second, tetrapeptide 32 accumulation led to a decrease in canonical UDP-pentapeptide precursors, reducing 33 PG synthesis. Thus, LdcV and the recycling pathway promote optimal cell wall 34 assembly and composition. Furthermore, Ldc substrate preference for 35 murotetrapeptides containing canonical (D-Alanine) vs. non-canonical (D-Methionine) 36 D-amino acids is conserved, suggesting that accumulation of tetrapeptide recycling 37 intermediates may modulate PG homeostasis in environments enriched in non-38 canonical-muropeptides via substrate competition.
INTRODUCTION 40
The bacterial cell shape-determining peptidoglycan (PG) cell wall, provides 41 resistance to cell turgor pressure and protection from environmental threats 1,2 . PG is Double deletion mutants, combining ΔldcV with deletions in most of identified 161 suppressors, were constructed to validate and extend our analysis of the putative 162 ldcV suppressors. Combining ΔldcV with individual deletions of PG recycling genes, 163 ampG (permease), ampD (amidase) or mpl (muropeptide ligase), yielded near 164 complete reversion of the ldcV phenotypic defects, which correlated with the absence 165 of detectable UDP-P4 ( Fig. 2d-f and Supplementary Fig. 5a-b) . However, the 166 ΔldcV ΔnagZ mutant accumulated UDP-P4 and incompletely suppressed the growth 167 and PG defects of the ΔldcV mutant ( Fig. 2d-f, Supplementary Fig. 5a-b) . accumulation in the nagZ ldcV mutant is likely explained by AmpD's catalytic 169 promiscuity 30 , which can release the tetrapeptide from both the anhydro-muramyl-170 peptide and the M4N (accumulated in the nagZ mutant background) 171 ( Supplementary Fig. 5c-d ) thereby promoting Mpl-dependent formation of UDP-P4. 172 Similarly, deletions in PG-hydrolytic enzymes only partially alleviated the ΔldcV 173 phenotypes and did not prevent UDP-P4 accumulation ( Fig. 2d-f) . Therefore, these 174 data suggest that in addition to UDP-P4 depletion, there is a second mechanism to 175 supress ΔldcV lethality. 176 PG hydrolases are also known as autolysins because their uncontrolled 177 activity upon cessation of PG synthesis can lead to cell lysis 31, 32, 33 . Therefore, we 178 hypothesized that inactivation of these enzymes could suppress ΔldcV's viability 179 defect by reducing autolysis. To monitor autolysis, we compared the amount of the 180 PG turnover product M4N in the extracellular medium in the wild-type strain and the 181 PG hydrolase mutants in a ΔampG background (to block PG recycling). There were 182 reduced amounts of extracellular M4N in all PG hydrolase mutants (Fig. 2g) , 183 suggesting that the hydrolase deletion mutants may relieve the toxicity associated 184 with the absence of LdcV by reducing PG turnover. Recycled tetrapeptides can be incorporated into peptidoglycan leading to 187 reduced cross-linkage 188 Höltje and colleagues speculated that the lytic phenotype of an E.coli ΔldcA 189 mutant results from incorporation of UDP-P4 into PG, which in turn causes a lethal 190 reduction in peptide cross-linkage 19 . However, incorporation of recycled tetrapeptides 191 into the PG matrix has not been experimentally verified. Lipid II is the final precursor 192 for PG synthesis 34 ; notably, most Lipid II extracted from the ldcV mutant was in the 193 tetrapeptide form rather than the native pentapeptide form found in the wild-type 194 ( Fig. 3a, Supplementary Fig. 6 ). To track whether recycled tetrapeptides can be 195 incorporated into the mature PG sacculus, we designed a strategy to distinguish 196 between tetrapeptides derived from the de novo pathway (ending with D-Ala) and 197 those from the recycling pathway. To this end, the growth medium was 198 supplemented with a "D-Met-labelled" anhydro-murotetrapeptide derivative (M4N Met ) 199 which can be recycled and detected as a D-Met tetrapeptide in the PG (Fig. 3b , 200 Supplementary Fig. 7a) . These experiments were carried out in a ΔldcV derivative 201 (referred to as Δ4) that was also deficient in endogenous D-Met production (due to 202 the absence of the BsrV racemase) and unable to incorporate exogenous D-Met by 203 L,D-transpeptidation 4 (due to the absence of LdtA and LdtB). M4 Met was detected in 204 the PG isolated from the M4N Met -treated Δ4 strain, but not in a control strain (Δ5), 205 where recycling was disabled via ampG inactivation ( Fig. 3c and Supplementary 206 Fig 7b) . Together, these observations demonstrate that the recycled tetrapeptides 207 that accumulate in the ldcV mutant are reused as substrates for PG synthesis.
208
In addition to accumulating tetrapeptide precursors, the ΔldcV mutants 209 exhibited a marked reduction in D,D-cross-links ( Fig. 3d, Supplementary Fig. 8a) . 210 We speculated that an increase in L,D-cross-links could compensate for the 211 reduction in D,D-cross-links in the ΔldcV mutant, since L,D-transpeptidases use 212 tetrapeptides instead of pentapeptides as substrates 35, 36 (Fig. 3e) . Consistent with 213 this idea, we found that expression of LdtA (the main L,D-transpeptidase of V. 214 cholerae) 4 increased the fitness of the ΔldcV mutant ( Fig. 3f, Supplementary Fig.   215 8b), whereas deletion of ldtA in the ΔldcV background further attenuated its growth 216 ( Fig. 3g) .
218
Recycled tetrapeptides reduce the abundance of UDP-MurNAc-pentapeptide 219 Besides the reduction in PG cross-links, we noticed a striking correlation 220 between accumulation of tetrapeptide precursors (Lipid II-P4 or UDP-P4) and a 221 reduction in canonical pentapeptide precursors ( Fig. 3a and Fig. 4a ). This result is 222 consistent with the reduced PG content of the ldcV mutant and suggests that 223 recycled tetrapeptide precursors negatively regulate de novo PG biosynthesis. We Therefore, our data suggest that competition between the de novo synthesis and 235 recycling pathways for available UDP-muramyl accounts for the reduction in the 236 amount of the UDP-P5 precursors in the ΔldcV mutant.
237
Also consistent with the hypothesis that UDP-P4 negatively regulates 238 pentapeptide levels, a Tn-seq based screen for ldcV genetic interactions revealed a 239 synthetic lethal/sick phenotype with the genes encoding V. cholerae's dominant high 240 molecular weight PBP1A (mrcA) and its regulatory partner proteins LpoA and CsiV 241 (vc0581 and vc1887 respectively) ( Fig. 4d ). Collectively, these observations buttress 242 the idea that LdcV plays a key role in maintaining a proper ratio between UDP-P5 243 and UDP-P4 to ensure optimal PG synthesis and composition (i.e. cross-linking).
245
Recycled non-canonical tetrapeptide precursors are detectable in wild-type V. 246 cholerae 247 We previously found that PG editing by non-canonical D-amino acids 248 (NCDAA) such as D-Met leads to accumulation of pentapeptides in the cell wall of 249 some bacteria, likely because these modified muropeptides are poor substrates for 250 D,D-carboxypeptidases 4 . We wondered whether NCDAA modified muropeptides 251 might also be sub-optimal substrates for LcdV, and lead to accumulation of recycled 252 tetrapeptides in the wild-type strain. Notably, targeted MS analysis of stationary 253 phase wild-type cytosolic extracts revealed the presence of UDP-tetrapeptide with D-254 Met at the terminal position (UDP-P4 Met ) ( Fig. 5a and Supplementary Fig. 10 ). In 255 contrast, UDP-tetrapeptides were not detected in extracts from the ΔampG mutant, 256 indicating that the source of these molecules is recycled anhydro-muropeptides ( Fig.   257 5a). Furthermore, we directly detected the presence of anhydro-murotetrapeptides 258 with D-Met (M4N Met ) in the extracellular medium ( Fig. 5b) . Like UDP-P4 Met , M4N Met 259 12 was exclusively detected in stationary phase ( Fig. 5b and Supplementary Fig. 9a ), 260 consistent with the stationary phase-limited expression of BsrV, the racemase that 261 generates D-Met 4 . Similarly, M4N Met was not detected in supernatants from a ΔbsrV 262 strain ( Supplementary Fig. 9b ). 263 To assess if accumulation of UDP-P4 Met could be due to LdcV's preference for hydrolyse both kind of substrates ( Fig. 5c) , it exhibits a preference for canonical over 269 D-Met-modified tetrapeptides ( Fig. 5d, Supplementary Fig. 9c ). The preference of 270 LdcV for canonical tetrapeptide substrates, could lead to accumulation of non-271 canonical tetrapeptide precursors in the wild-type strain (functional LdcV).
272
Furthermore, additional LdcV-like (from Aeromonas hydrophila and Proteus mirabilis) 273 and LdcA-like (from E. coli and Salmonella enterica) L,D-carboxypeptidases exhibit 274 similar preference for canonical rather than NCDAA-modified murotetrapeptides 275 substrates ( Supplementary Fig. 9d ). Thus, the recycling of NCDAA-edited PG and 276 subsequent production of precursor tetrapeptides could underlie a conserved 277 mechanism linking NCDAA editing with the control of PG synthesis. prevented UDP-P4 formation, thus preventing its toxic effects on PG biogenesis, 294 whereas others (e.g. inactivation of slt) reduced PG turnover. Moreover, our 295 observations suggest that the lethality of ΔldcV is caused by two distinct 296 mechanisms: 1) incorporation of recycled UDP-P4 into the murein (Fig. 3) , which 297 leads to a decrease in PG cross-linkage; and 2) a reduction of the canonical UDP-P5 298 precursor pool ( Fig. 4) , which leads to a reduction of PG synthesis. the high molecular weight PBPs, we found that LdtA, an L,D-transpeptidase that 316 uses tetrapeptides as donor substrates 4 , can compensate for the growth defect of the 317 ldcV mutant in low osmolarity ( Fig. 3, Supplementary Fig. 8b) . Interestingly, a 318 number of bacterial species lack Ldc orthologues, despite apparently encoding other 319 components of the PG recycling pathway (e.g. Yersinia pestis and Acinetobacter 320 baumanni 12 ). In organism lacking Ldc homologues, we hypothesize that L,D-321 transpeptidases (Ldts) may play more prominent roles in maintaining PG 322 homeostasis. Moreover, our data suggests that inhibition of Ldc (e.g., with nocardicin 323 A) in combination with inhibitors of Ldts (e.g., imipenem) 40 and/or PBP1a (e.g. beta- modified tetrapeptide precursors -that together coordinate cell wall synthesis with 337 growth arrest (Fig. 6i) . It is also possible that in addition to auto-regulatory roles, 338 production of NCDAA induces regulatory changes in the murein of neighbouring 339 organisms ( Fig. 6ii-iii) . In principle, any bacterium that incorporates NCDAA in the 340 4 th position of the muropeptides (e.g. via the activity of Ldts) is a potential source of 341 NCDAA-modified anhydromuropeptides that could modulate PG 342 synthesis/composition in bacteria inhabiting the same niche (Fig. 6) . 343 Finally, extracellular PG fragments are known to be important signals in innate 344 immunity, organ development and behaviour [41] [42] [43] [44] [45] . Our observation that bacteria can 345 release PG fragments modified with NCDAA suggests that it will be important to 346 consider whether NCDAA-modified PG fragments convey distinct information in inter-347 kingdom signalling compared to fragments modified with canonical DAA. Moreover, 348 in microbial ecology (Fig 6) , our findings suggest that release of extracellular non- vc2153 mutations accumulate suppressors, the deletion of vc2153 was always the 372 final mutation introduced in strains bearing inactivation of more than one gene.
373
Complementation and overexpression plasmids were constructed using the Murein sacculi isolation and muropeptide analysis were performed essentially 397 as described previously [51] [52] [53] . Briefly, bacterial pellets of 50 ml (exponential phase 398 OD600 ∼0.4) or 25ml (stationary phase OD600 ∼3) cultures were boiled in 5% SDS.
399
Cell wall material was pelleted and repeatedly washed with water by 400 ultracentrifugation. Clean sacculi were digested with muramidase (100 µg/ml) and 401 soluble muropeptides were then reduced using 0.5 M sodium borate pH 9.5 and 402 sodium borohydride at 10 mg ml -1 (final concentration). The pH of the samples was 403 adjusted to 3.5 with phosphoric acid for liquid chromatography. between the tetra-tetra dimer (D44) and the tetra monomer (M4) was calculated. All 420 PG analyses were preformed using biological triplicates. 
443
Acetonitrile and formic acid were used as organic solvents for peak separation.
444
Collected peaks were lyophilized, dissolved in water, and stored at -20 °C.
445
In vitro reactions were prepared in a final volume of 50μl containing as 446 substrates either pure muropeptides (10ug), intact sacculi or muramidase-digested follows: 0-3 min 5%, 3-6 min 5-6.8%, 6-7.5 min 6.8-9%, 7.5-9 min 9-14%, 9-11 min 518 24 14-20%, 11-12 min hold at 20% with a flow rate of 0.175 ml/min; 12-12.10 min 20-519 90%, 12.1-13.5 min hold at 90%, 13.5-13.6 min 90-2%, 13.6-16 min hold at 2% with 520 a flow rate of 0.3 ml/min; and then 16-18 min hold at 2% with a flow rate of 0.25 521 ml/min. Chromatograms were recorded at 204 nm. The QTOF-MS instrument was processing was performed using UNIFI software package (Waters Corp.).
532
The molecular structure of each anhydro-muropeptide and the PG precursor 533 molecules was obtained using ChemSketch 65 to build a compound library in UNIFI.
534
This compound library was used for processing the data, to detect and identify each Lipid extraction was performed according to the protocol described by Quiao 543 et al. 66 for "large-scale lipid extraction" but using only 500 ml cultures. Strains were 544 grown in LB at 37 °C until an OD600 of 0.4-0.6 or 2 for exponential or stationary phase 545 samples respectively. After the chloroform/methanol extraction steps, dried 546 recovered interface fractions were resuspended in DMSO. The lipid tail of the 547 extracted Lipid II was removed by ammonium acetate treatment before LC-MS 548 analysis that was performed by targeted MS using the same parameters indicated 549 above for analysing soluble-muropeptides pools. In vitro competition indices (CI) were determined from cultures containing the 567 ΔldcV strain (lacZ + ) carrying the empty pBAD18 vector and the ΔldcV (lacZ -) with the 568 specified pBAD18::Mur-construction, mixed in a ratio 5:1. The competition assays 569 were performed by incubating the cultures in LB0 and appropriate antibiotics 570 supplemented with 0.2% of arabinose for 4h at 37 °C. After this time, CFUs were 571 counted by plating serial log dilutions on LB0 agar containing Sm, Km, 0.2% 572 arabinose and X-gal 40 μg ml -1 . The CI was defined as the number of white colonies 573 (strains overexpressing Mur proteins)/number of blue colonies (empty vector) 574 counted after the incubation, divided by the white/blue ratio measure in the inoculum.
575
The competition assays were performed in triplicates. 
